Jump to Navigation Skip to main content

Awards & Funding

Education

Events

Research

Newsroom

Dr. Antoni Ribas

UCLA opens first engineered blood stem cell clinical trial for cancers with the NY-ESO-1 tumor marker

Untreated mouse skin showing no hair growth (left) compared to mouse skin treated with the drug UK5099 (right) showing hair growth

UCLA scientists identify a new way to activate stem cells to make hair grow

Steve Jonas - Alex’s Lemonade Stand Foundation.

Stem cell center trainee receives grant to develop nanotechnologies to treat pediatric cancer

Lab Candid

Two UCLA scientists receive CIRM Discovery Grants for stem cell research

Illustration of mice adapting to their custom-designed space habitat on board the International Space Station.

Mice headed for space to test bone-building drug developed at UCLA

Ovarian cancer tumors with higher percentages of cIAP-expressing cells, shown in red at left, were more sensitive to a potential combination therapy than tumor cells without cIAP-expressing cells.

Combination therapy could provide new treatment option for ovarian cancer

Left: axons (green, pink, blue) form organized patterns in the normal developing mouse spinal cord. Right: removing netrin1 results in highly disorganized axon growth.

Study overturns seminal research about the developing nervous system

Andrew Goldstein in lab

Goldstein receives grant to study role of molecule in prostate cancer

T cells (red) produced using artificial thymic organoids developed at UCLA.

Artificial thymus developed at UCLA can produce cancer-fighting T cells from blood stem cells

Evangelina Vaccaro received Dr. Kohn’s treatment for bubble baby disease in 2012.

Study analyzes safety and effectiveness of stem cell gene therapy for bubble baby disease

Pages